AMLX — AMYLYX PHARMACEUTICALS INC

Ownership history in Quantbot Technologies LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Quantbot Technologies LP reported a position in AMYLYX PHARMACEUTICALS INC (AMLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q1)
Avg. % of fund
0.01%
First filed
2022 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 16,653 +11,794 +242.7% 0.01% $226K $13.59
2023 Q1 ADDED 4,859 +2,659 +120.9% 0.01% $143K $29.34
2022 Q1 INITIATED 2,200 — — 0.00% $28K $12.85
% of Fund (quarterly)    AMLX price (monthly, adj. close)

Other funds also holding AMLX

As of 2025 Q4 — sorted by position size

Saturn V Capital Management LP 3Y 9.97% GREAT POINT PARTNERS LLC 3Y 7Y 6.85% Almitas Capital LLC 3Y 7Y 5.65% Commodore Capital LP 3Y 4.54% First Light Asset Management, LLC 3Y 7Y 3.1% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 2.73% TCG Crossover Management, LLC 3Y 2.5% Aldebaran Capital, LLC 3Y 2.15% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.78% STEMPOINT CAPITAL LP 1.17%
← Back to Quantbot Technologies LP Holdings